Trial Profile
Study of landiolol in congestive heart failure patients with supraventricular tachyarrhythmias
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 18 Dec 2015
Price :
$35
*
At a glance
- Drugs Landiolol (Primary)
- Indications Heart failure
- Focus Adverse reactions; Therapeutic Use
- 18 Dec 2015 New trial record